IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 76.987
EU - Europa 43.056
AS - Asia 41.472
SA - Sud America 9.180
AF - Africa 1.055
Continente sconosciuto - Info sul continente non disponibili 159
OC - Oceania 83
Totale 171.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 73.046
SG - Singapore 15.074
RU - Federazione Russa 10.952
CN - Cina 10.304
IT - Italia 9.407
GB - Regno Unito 8.424
BR - Brasile 7.143
VN - Vietnam 6.009
DE - Germania 2.995
HK - Hong Kong 2.967
CA - Canada 2.784
UA - Ucraina 2.661
BD - Bangladesh 2.593
FR - Francia 1.613
DK - Danimarca 1.587
FI - Finlandia 1.106
SE - Svezia 1.052
IN - India 913
MX - Messico 763
IE - Irlanda 762
AR - Argentina 710
PL - Polonia 709
NL - Olanda 543
TR - Turchia 506
ID - Indonesia 428
IL - Israele 411
EC - Ecuador 371
ZA - Sudafrica 368
ES - Italia 341
IQ - Iraq 337
JP - Giappone 336
PK - Pakistan 296
CO - Colombia 244
AT - Austria 201
VE - Venezuela 193
MA - Marocco 174
UZ - Uzbekistan 159
CL - Cile 149
EU - Europa 149
AE - Emirati Arabi Uniti 135
LT - Lituania 130
SA - Arabia Saudita 130
PY - Paraguay 129
MY - Malesia 102
EG - Egitto 98
PH - Filippine 95
PE - Perù 94
KE - Kenya 91
TN - Tunisia 84
KR - Corea 76
UY - Uruguay 71
DZ - Algeria 69
JO - Giordania 68
CH - Svizzera 62
JM - Giamaica 62
CR - Costa Rica 60
IR - Iran 60
BE - Belgio 59
BO - Bolivia 59
NP - Nepal 54
AU - Australia 53
SK - Slovacchia (Repubblica Slovacca) 53
AZ - Azerbaigian 48
HN - Honduras 48
RO - Romania 46
CZ - Repubblica Ceca 41
DO - Repubblica Dominicana 40
AL - Albania 39
KZ - Kazakistan 39
PT - Portogallo 37
TW - Taiwan 35
ET - Etiopia 33
OM - Oman 32
NI - Nicaragua 31
TH - Thailandia 31
GT - Guatemala 27
KG - Kirghizistan 27
TT - Trinidad e Tobago 26
HU - Ungheria 25
GR - Grecia 24
PA - Panama 24
AM - Armenia 23
LB - Libano 23
PS - Palestinian Territory 22
RS - Serbia 22
CI - Costa d'Avorio 21
SN - Senegal 21
GE - Georgia 20
KW - Kuwait 19
NZ - Nuova Zelanda 19
SV - El Salvador 19
NO - Norvegia 18
LV - Lettonia 17
SI - Slovenia 17
BG - Bulgaria 16
BH - Bahrain 16
QA - Qatar 16
BB - Barbados 15
MD - Moldavia 15
NG - Nigeria 14
Totale 171.680
Salva come PNG Salva come JPEG
Città #
Dallas 13.954
Singapore 7.641
Southend 5.518
San Jose 4.889
Ashburn 4.831
Beijing 4.067
Woodbridge 2.869
Hong Kong 2.705
Chandler 2.556
Ann Arbor 2.547
Houston 2.373
Los Angeles 2.204
Moscow 1.997
Fairfield 1.914
Chicago 1.861
San Mateo 1.857
Ho Chi Minh City 1.732
Milan 1.585
Falls Church 1.553
Seattle 1.345
Dearborn 1.328
New York 1.234
Jacksonville 1.214
The Dalles 1.180
Wilmington 1.160
Cambridge 1.154
Hanoi 1.082
Rome 999
Ottawa 955
Buffalo 897
Santa Clara 811
Hefei 807
Lauterbourg 798
São Paulo 761
Salt Lake City 760
Boardman 745
Dublin 742
Stevenage 685
Portsmouth 683
Council Bluffs 682
Pisa 656
Warsaw 643
Dong Ket 641
Helsinki 555
Lawrence 525
Brooklyn 463
Beauharnois 444
Orem 438
Tampa 430
Munich 415
Montréal 406
Montreal 379
London 376
Elk Grove Village 363
Tel Aviv 356
Mexico City 348
Frankfurt am Main 296
Tokyo 288
Florence 284
Denver 270
Chennai 267
Columbus 265
Rio de Janeiro 250
Atlanta 238
Johannesburg 235
Stockholm 235
Istanbul 231
Amsterdam 227
San Diego 227
Toronto 226
Phoenix 225
Poplar 223
Figino 219
Da Nang 210
Haiphong 198
Nuremberg 194
Boston 171
Turin 167
Sterling 165
Redwood City 161
Lancaster 158
Miami 158
Old Bridge 158
Naples 155
Bologna 150
Belo Horizonte 145
Tashkent 144
San Francisco 142
Brasília 139
Manchester 135
Guangzhou 133
Lappeenranta 132
Guayaquil 127
Biên Hòa 123
Ankara 120
Curitiba 119
Mumbai 118
Central District 114
Washington 114
Turku 113
Totale 104.282
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.843
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.704
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.576
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.359
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 890
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 729
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 617
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 598
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 506
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 500
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 487
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 481
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 450
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 436
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 431
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 417
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 405
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 397
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 392
A simple echocardiographic score to rule out cardiac amyloidosis 388
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 382
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 381
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 378
Cartella clinica automatizzata per il reparto di cardiologia 373
An Open System for Managing Long Term ECG Recordings 369
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 368
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 362
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 361
Building medical knowledge from real world registries: The case of heart failure 359
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 356
A simple echocardiographic score to rule out cardiac amyloidosis 354
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 353
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 348
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 344
La neuropatia diabetica 342
Central sleep apnea and cardiovascular disease state-of-the-art 341
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 339
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 336
[Central apneas and cardiovascular diseases] 335
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 333
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 331
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 331
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 330
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 330
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 329
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 326
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 326
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 325
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 325
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 325
Treating chemoreflex in heart failure: modulation or demolition? 324
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 324
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Prediction of the chemoreflex gain by common clinical variables in heart failure 323
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 322
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 321
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 318
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 316
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 315
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 315
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 314
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 314
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 311
Adrenergic activation in heart failure: blockade or rebalance? 309
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 309
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 307
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 306
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 306
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 306
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 305
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 304
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 303
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 302
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 302
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 300
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 300
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 300
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 300
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 299
Eligibility for vericiguat in a real‐world, contemporary heart failure population 299
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 299
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 298
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 298
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 297
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 297
Effects of smoking in patients treated with cardiac resynchronization therapy 297
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 295
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 295
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 293
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 293
[Ten perspectives for research and innovation in cardiac amyloidosis] 291
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 291
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 291
Screening the health status of people working in a university 290
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 290
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 290
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 288
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 286
Totale 40.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 838.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 838.628
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.621 0 0 0 0 0 0 0 0 0 0 0 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/202686.069 4.297 13.612 10.203 10.763 8.532 5.113 8.848 3.768 5.099 5.501 5.107 5.226
Totale 173.035